Skystar Bio-Pharmaceutical Company (SKBI)
Create an AlertSkystar Bio-Pharmaceutical Company PE Ratio TTM:
1.535 for June 17, 2013Skystar Bio-Pharmaceutical Company Historical PE Ratio TTM Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 17, 2013 | 1.535 |
| June 14, 2013 | 1.499 |
| June 13, 2013 | 1.487 |
| June 12, 2013 | 1.583 |
| June 11, 2013 | 1.595 |
| June 10, 2013 | 1.571 |
| June 7, 2013 | 1.595 |
| June 6, 2013 | 1.775 |
| June 5, 2013 | 1.475 |
| June 4, 2013 | 1.775 |
| June 3, 2013 | 1.799 |
| May 31, 2013 | 1.679 |
| May 30, 2013 | 1.583 |
| May 29, 2013 | 1.475 |
| May 28, 2013 | 1.439 |
| May 24, 2013 | 1.475 |
| May 23, 2013 | 1.440 |
| May 22, 2013 | 1.499 |
| May 21, 2013 | 1.439 |
| May 20, 2013 | 1.415 |
| May 17, 2013 | 1.439 |
| May 16, 2013 | 1.499 |
| May 15, 2013 | 1.703 |
| May 14, 2013 | 1.703 |
| May 13, 2013 | 1.796 |
| May 10, 2013 | 1.751 |
| May 9, 2013 | 1.775 |
| May 8, 2013 | 1.775 |
| May 7, 2013 | 1.772 |
| May 6, 2013 | 1.727 |
| May 3, 2013 | 1.715 |
| May 2, 2013 | 1.799 |
| May 1, 2013 | 1.68 |
| April 30, 2013 | 1.739 |
| April 29, 2013 | 1.787 |
| April 26, 2013 | 1.865 |
| April 25, 2013 | 1.739 |
| April 24, 2013 | 1.74 |
| April 23, 2013 | 1.739 |
| April 22, 2013 | 1.739 |
| April 19, 2013 | 1.799 |
| April 18, 2013 | 1.871 |
| April 17, 2013 | 1.859 |
| April 16, 2013 | 1.859 |
| April 15, 2013 | 1.883 |
| April 12, 2013 | 1.859 |
| April 11, 2013 | 1.859 |
| April 10, 2013 | 1.864 |
| April 9, 2013 | 1.835 |
| April 8, 2013 | 1.916 |
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More
SKBI PE Ratio TTM Benchmarks
| Companies | |
|---|---|
| Abbott Laboratories | 11.18 |
| Daiichi Sankyo | 21.78 |
| Astellas Pharma | 29.55 |
SKBI PE Ratio TTM Rankings
| Overall |
99th percentile 114 of 16770 |
| Sector |
99th percentile 12 of 1408 in Healthcare |
| Industry |
97th percentile 3 of 135 in Drug Manufacturers - Major |
SKBI PE Ratio TTM Range, Past 5 Years
| Minimum | 0.7769 | Oct 6 2011 |
| Maximum | 15.48 | Nov 16 2009 |
| Average | 3.947 |
